21 CFR Subpart A
General Labeling Provisions
June 25, 2020
§
201.16
Drugs; Spanish-language version of certain required statements
§
201.17
Drugs; location of expiration date
§
201.18
Drugs; significance of control numbers
§
201.19
Drugs; use of term “infant”
§
201.1
Drugs; name and place of business of manufacturer, packer, or distributor
§
201.2
Drugs and devices; National Drug Code numbers
§
201.5
Drugs; adequate directions for use
§
201.6
Drugs; misleading statements
§
201.10
Drugs; statement of ingredients
§
201.15
Drugs; prominence of required label statements
§
201.20
Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use
§
201.21
Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use
§
201.22
Prescription drugs containing sulfites; required warning statements
§
201.23
Required pediatric studies
§
201.24
Labeling for systemic antibacterial drug products
§
201.25
Bar code label requirements
§
201.26
Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
